The capsule polysaccharide structure and biogenesis for non-O1 Vibrio cholerae NRT36S: genes are embedded in the LPS region
© Chen et al; licensee BioMed Central Ltd. 2007
Received: 30 August 2006
Accepted: 15 March 2007
Published: 15 March 2007
In V. cholerae, the biogenesis of capsule polysaccharide is poorly understood. The elucidation of capsule structure and biogenesis is critical to understanding the evolution of surface polysaccharide and the internal relationship between the capsule and LPS in this species. V. cholerae serogroup O31 NRT36S, a human pathogen that produces a heat-stable enterotoxin (NAG-ST), is encapsulated. Here, we report the covalent structure and studies of the biogenesis of the capsule in V. cholerae NRT36S.
The structure of the capsular (CPS) polysaccharide was determined by high resolution NMR spectroscopy and shown to be a complex structure with four residues in the repeating subunit. The gene cluster of capsule biogenesis was identified by transposon mutagenesis combined with whole genome sequencing data (GenBank accession DQ915177). The capsule gene cluster shared the same genetic locus as that of the O-antigen of lipopolysaccharide (LPS) biogenesis gene cluster. Other than V. cholerae O139, this is the first V. cholerae CPS for which a structure has been fully elucidated and the genetic locus responsible for biosynthesis identified.
The co-location of CPS and LPS biosynthesis genes was unexpected, and would provide a mechanism for simultaneous emergence of new O and K antigens in a single strain. This, in turn, may be a key element for V. cholerae to evolve new strains that can escape immunologic detection by host populations.
Vibrio cholerae has three forms of surface polysaccharide, although some strains do not express all three forms: a lipopolysaccharide (LPS) inserted in the outer membrane, a capsule composed of high molecular weight polysaccharide that forms a dense thick coat outside of the bacterial cells, and a loose slime-like exopolysaccharide. Unlike V. cholerae of serogroup O1, which causes cholera, most non-O1 isolates have capsular polysaccharide (CPS) in addition to LPS. The LPS of V. cholerae is a protective antigen for cholera [1, 2], with over 200 serogroups identified based on the O-antigen of the LPS. The O-antigen biogenesis loci of 4 serogroups (O1, O139. O22, O37) have been sequenced and characterized, and have been found to reside between two genes, gmhD and rjg, in the genome [3–7]. More than 85% of non-O1 V. cholerae isolates have a capsule that is critical for virulence in extraintestinal infections . However, in contrast to E. coli, in which extensive work has been done on capsule structure and genetics (with associated classification into groups by Whitfield and Roberts ), structures and the genetics of CPS in V. cholerae are poorly understood.
The one strain for which data on capsule structure and genetics are available is the newly emerged epidemic strain V. cholerae O139. This strain has a capsule that appears to have arisen from the replacement of the O1 antigen biosynthetic region with a new gene cluster in the genetic background of an O1 strain [5, 6], resulting in emergence of a strain to which the human population did not yet have immunity. The capsule in O139 is unusual in that it shares the same repeating subunit as the O-antigen [10–12]. Therefore, the polysaccharide in O139 appears as both capsule and LPS and resembles the KLPS in the group 4 E. coli capsule .
There are limited studies on the genetics of polysaccharide biogenesis for the genus Vibrio. In V. vulnificus the CPS is a primary virulence factor and hence has been the target of more intensive study . An operon including genes wza, wzb and wzc was identified as part of the CPS genes for V. vulnificus strain M06-24 [14, 15], consistent with the presence of a group 1 capsule. The genetic loci for CPS were also identified in another strain of V. vulnificus 1003 . A wzx/wzy system was present for polymerization and exporting the CPS. However, the genetic region responsible for LPS biosynthesis has not been identified in V. vulnificus.
The elucidation of capsule structure and biogenesis is critical to understanding the evolution of surface polysaccharide and the internal relationship between the capsule and LPS in this species. It also has clear implications for understanding the behavior of this species within human populations, as the ability to change these surface antigens to avoid host immunologic detection is a key feature underlying the ability of V. cholerare to survive. Here, we report the covalent structure and studies of the biogenesis of the capsule in V. cholerae NRT36S.
Results and discussion
Structure of the CPS
Results of methylation analysis.
2- and 4-linked Gal
3- and 4-linked Gal
3- and 6-linked Gal
4- and 6-linked Gal
4- and 6-linked GlcNAc
Nuclear magnetic resonance (NMR) results
NMR spectra of the native polysaccharide are complex, showing a number of peaks in the anomeric region that are not in simple stoichiometric ratios. Likewise, the acetyl methyl region (2.0 – 2.3 ppm) shows approximately 10 peaks not in simple ratios suggesting that the polysaccharide may be heterogeneously substituted with O-acetyl functions. Therefore the sample was treated with aqueous ammonium hydroxide, which is expected to cleave O-acetyl groups by mild base catalyzed hydrolysis. The NMR spectra of the resulting sample (de-O-acetyl polysaccharide) showed only two peaks in the acetyl methyl region (2.06 and 2.09 ppm) and a greatly simplified pattern in the anomeric region with four distinct signals in the C-H HSQC (heteronuclear single quantum correlation) spectrum. We show below that the peaks at 2.06 and 2.09 arise from N-acetyl groups.
Complete assignment of the NMR spectra of the de-O-acetylated polysaccharide
NRT36 (deOAc) ~50°C (321 K)
Residue linkages for the capsular polysaccharide of V. cholerae NRT36S
Complete assignment of the NMR spectra of the mono-O-acetylated polysaccharide
NRT36 Mono-O-Acetyl ~50°C
a.) Shifts enclosed in parentheses are those of the 3-O-acetylated B residue in the native polysaccharide.
assignment of NAc's, OAc's
C = O
C: β-L-Rha OAc
The acetate methyl region of the NMR spectrum of the native, untreated, polysaccharide shows a number of peaks including those assignable to the amides of residue B and D and of the 2-O-acetyl group of residue C along with smaller peaks indicating partial O-acetylation at other positions. Using HMBC spectra, it was possible to correlate methyl proton signals, through carbonyl carbon resonances, to sugar ring protons indicating positions of acetyl substitution. In addition to the 2-O-acetyl of residue C, it was possible to identify an O-acetyl group on the 3-position of residue B to the extent of about 50% as indicated in Table 4. Anomeric resonances of residue A were split into three peaks in the native polysaccharide suggesting partial O-acetylation of that residue but the exact positions could not be definitively assigned.
Although the chromatographic data indicate that the sample contains galactose, it is not part of the capsular polysaccharide. The NMR data of Figure 1 are consistent with four residues per repeating subunit and no sign of any galactose. Although the NMR spectra show minor peaks at approximately 10% level, none are characteristic of carbohydrates and they show no connection to the peaks assigned for the polysaccharide structure by NOESY or HMBC spectra.
The structure proposed here for the NRT36S capsule repeating subunit is very similar to that reported for the V. cholerae O6 lipopolysaccharide . The polysaccharide backbones are identical differing only in the degrees of O-acetylation. Bergstrom et al reported stoichiometric O-acetylation at both C2 of rhamnose and at C3 of α-GlcNAc while our structure for native capsular polysaccharide of V. cholerae NRT36S is only partially substituted at C3 of α-GlcNAc along with lower degrees of acetylation at other positions. In spite of these differences, the NMR data reported by Bergstrom et al  are quite close to those reported for our native structure in Table 4.
Transposon mutagenesis and mutant selection
The conjugations between wild type Vibrio cholerae NRT36S and donor strain E. coli S17λpir/putKm-2 generated 20,615 mutants of NRT36S, each carrying a single copy of the transposon Km-2 in its genome. Among these mutants, 411 colonies displayed a translucent phenotype on LB agar. This phenotype suggests that genes involved in capsule biogenesis have been disrupted by the transposon .
DNA analysis of mutants
CPS genes (bold print) identified by transposon mutagenesis
Gene in CPS region
Putative gene functions
Best hit (AAI)
CYS regulon transcriptional activator
V. cholerae (100%)
FadR fatty acid metabolism regulator protein
V. cholerae (100%)
V. cholerae (100%)
Ubiquinol cytochrome C reductase
V. cholerae (100%)
Orf23 ( galE )
Nucleoside-diphosphate sugar epimerase
V. cholerae (98%)
Nitrosospira multiformis (40%)
Shewanella sp . (66%)
Orf5 ( wzm )
ABC transporter system integral membrane protein
Raoultella terrigena (55%)
Immuno blotting and size exclusion chromatography (SEC)
Electron microscopy (EM)
Sequencing of the V. cholerae NRT36S genome
V. cholerae NRT36S genome was sequenced by the company 454 Life Sciences. The sequencing runs have generated 1,082,967 reads and output 104,531,256 bases of sequence. The estimated coverage depth was 26X. The draft genome consisted of 184 contigs with total length of 3.9 million bases. The average GC (guanine-cytosine) content for the draft genome was 47.5%. The draft genome was annotated [21, 22]. For the purpose of the discussion in this paper, only those features related to the polysaccharide biogenesis will be discussed.
Genetics of the polysaccharide biogenesis
We located the capsule biogenesis genes identified by transposon mutagenesis in the NRT36S genome (Table 5). To our surprise, the 4 putative capsule structural genes identified by transposon mutagenesis were all located between the genes gmhD and rjg, the region considered to encode O-antigen biogenesis (Figure 6). Theses four genes were knocked out by at least one of 5 independent transposition events and caused the translucent phenotype associated with the loss of the capsule in each case. Therefore, we believe that the O-antigen biogenesis region in V. cholerae NRT36S is also the capsule biogenesis region.
Genes in the CPS/O-antigen biogenesis region
ABC transporter system integral membrane protein
ABC transporter system ATPase component
probable acetyl transferase by domain
putative glycosyl transferase
nucleoside-diphosphate sugar epimerase
UDP-glucose 4-epimerase VC0262
Trypsin-like serine proteases
hypothetical protein wbfC, periplasmic
hypothetical protein wbfD
Periplasmic protein involved in capsular polysaccharide export
Putative tyrosine-protein kinase Wzc
Putative saccharide polymerase
Putative sugar acetyltransferase
COG0110, Cytophaga hutchinsonii
Undecaprenylphosphate N-acetylglucosamine 1-phosphate transferase
Predicted exonuclease of the beta-lactamase fold involved in RNA processing
There were 12 glycosyltransferase genes identified. The precise function of most of them remained to be elucidated. Orf45 (wecA) was an undecaprenylphosphate N-acetylglucosamine 1-phosphate transferase gene. WecA was putatively the initial transferase to catalyze the transfer of N-acetylglucosamine 1-phosphate to undecaprenylphosphate in the capsule polysaccharide synthesis.
The structural data for V. cholerae NRT36S indicate that the capsule contains, one residue each of rhamnose and glucuronic acid and two N-acetyl-glucosamine residues, genes for whose synthesis are present in the CPS region. There are two sets of genes that are almost identical (orf1-4, and orf33-36) for L-rhamnose synthesis; they were rmlB, rmlA, rmlC, and rmlD in the order. L-rhamnose is commonly present in bacterial polysaccharides and the genes to synthesize it are normally clustered. For example in V. cholerae isolates with LPS serotypes O6, O12, O14, O19 and O151, the 4 orfs following gmhD are rmlB, rmlA, rmlC, and rmlD . Orf43 may be the rhamnosyltransferase to catalyze the addition of rhamnose to the CPS backbone. The disruption orf43 by the transposon both resulted in the loss of the capsule. This observation is consistent with the presence of rhamonse in the repeating polysaccharide backbone of the capsule. Orf23 was gene galE; its product UDP-glucose 4-epimerase catalyzed the conversion of UDP-glucose to UDP-galactose. Disruption of galE gene in mutant TR3 caused the loss of the capsule. Orf24 (wbeW) transfers galactose to the capsule complex. Orf 41, a sugar O-acetyltransferase homologue could be involved in the observed O-acetylation of the capsule, but this modification of bacterial polysaccharides is not well understood and other genes may be involved as well. Orf11, 12, 22, 37, 41 and 44 were also putative pathway genes for the synthesis of nucleotide sugar precursors, but their precise functions were not clear to us.
Translocation and processing genes
An ABC-2 type transporter system consisted of wzm and wzt were present in the CPS/O-antigen region. When wzm was disrupted by transposon mutagenesis, the mutant was non-capsulated (Table 5). Orf38 was predicted as a polysaccharide translocase gene wzx. Orf40 was predicted to have several transmembrane domains by the Dense Alignment Surface (DAS) program  and were assigned as putative wzy. Three genes wza, wzb and wzc were also present in the CPS/O-antigen region. The proteins Wza, Wzb and Wzc in E. coli formed a system that was involved in the exportation of E. coli group 1 capsular polysaccharides .
The disruption of an ABC transporter system integral membrane protein gene wzm had significantly reduced the amount of capsule (Figure 3B) in our experiments and resulted in the translucent colonies that were susceptible to serum killing. Examination of the CPS region also revealed the existence of wzt, which is another component of the ABC transporter system. Our results suggest that the processing and translocation of the capsule in V. cholerae NRT36S involves the ABC transporter system. There was a recent report that an ABC transporter system was involved in the transportation of hetero-polysaccharides in the O-antigen of E. coli O52 . Our results may be another case where an ABC transporter system was involved in the transportation of a hetero-polysaccharide.
Sharing of the same region by CPS and LPS
The O-antigen genes had been identified for several serogroups in V. cholerae, including O1, O139, O22 and O37 [3, 4, 6, 7, 23]. In these serogroups, the gene cluster for O-antigen biogenesis all resided between the genes gmhD and rjg. In our study of V. cholerae NRT36S genome, there was a gene cluster identified as the LPS core biogenesis region upstream of the gmhD gene (data not shown). There was also another gene cluster in the genome that was identified as the rugose-associated exopolysaccharide biosynthesis region (data not shown). The homologs of these genes were recognized as exopolysaccharide genes that related to the rugose phenotype in V. cholerae O1 El Tor . Besides these regions, i. e., the LPS core genes and the rugose exopolysaccharide genes, there were no other significant gene clusters for polysaccharide synthesis in the genome of V. cholerae NRT36S. All of this evidence supported the conclusion that the CPS region, i.e. the region between gmhD and rjg genes, is indeed also the O-antigen gene cluster. The immuno blot showed that the LPS had been altered in the non-encapsulated mutants. That not only confirmed the sharing of the CPS and LPS region, but also indicated that some genes may be shared by the biogenesis of the two polysaccharide structures. A potential test of this suggestion would be to determine whether the genes other than those encoding rhamnose synthesis involved in the O6 LPS serotype are related to the genes in NRT36S since the two organisms have LPS and capsule structures that are nearly identical.
CPS and O-antigen shared the same genetic locus in V. cholerae NRT36S. This differs from the organization of CPS and O-antigen gene clusters in E. coli. In E. coli, CPS gene clusters and the O-antigen gene clusters are different . The CPS genes from other gram-negative bacteria including Haemolyticus influenza, Salmonella typhi and Neisseria meningitidis have been cloned and characterized [31–36]. The organizations of most of them resemble E. coli. No LPS genes have been reported to embed inside the CPS gene cluster for these species except in N. meningitides. In N. meningitides group B, the mutations of two CPS biosynthesis genes (synX or synC) and another gene next to the CPS region, galE gene, were shown to affect the lipooligosaccharide structure [33, 36]. The CPS and O-antigen in group 4 E. coli consist of the same molecule. This arrangement is also seen in V. cholerae O139 where CPS and O-antigen are encoded by the same genetic locus and have identical repeating subunits. NRT36S is an O31 serogroup. Kondo's group found that the LPS of O31 in V. cholerae contains L-glycero-D-mannoheptose, glucose, fructose, galactose, glucosamine and an unknown amino sugar A2 . L-rhamnose was not found in the LPS, while our study found L-rhamnose in the CPS, suggested that CPS and LPS are two distinct structures in V. cholerae NRT36S. The antiserum against NRT36S detected LPS but not the capsule, again suggested that the O-antigen and CPS were two different entities. Our finding represents a new type of genetic organization of polysaccharide genes and raises a question of differential regulation of the genes for expression of capsule and O-antigen polysaccharides.
The genes for bacterial surface polysaccharide biogenesis were typically found in a cluster with an atypical GC content compared to the rest of the genome . It had been suggested that bacteria could convert to a new serogroup by acquiring a new O-antigen biogenesis region. There was abundant evidence that V. cholerae O139 arose from an O1 strain by receiving a new O-antigen gene cluster [5, 39, 40]. The sharing of CPS and O-antigen in V. cholerae, as indicated in our findings, makes this region one interchangeable unit. It is possible that V. cholerae can acquire a new gene cluster and give rise to a new strain with an O-antigen and K-antigen at the same time, both unrecognizable to the host immune system. This, in turn, may be a key element in its ability to survive, permitting rapid emergence of new strains that can escape immunologic detection by host populations.
Bacterial strains and culture conditions
V. cholerae NRT36S is an isolate originally cultured from a Japanese patient with travelers' diarrhea. It is serogroup O31, cholera toxin negative and produces a heat stable enterotoxin NAG-ST . When fed to volunteers this strain caused diarrhea, including, in one patient, a 5.3-liter diarrheal purge . Wild type V. cholerae NRT36S produces a capsule . This strain is resistant to polymyxin B but sensitive to kanamycin.
Transposon mini-Km2 was carried in the plasmid putKm-2 and maintained in the host strain E. coli S17λpir. Mini-Km2 was found to randomly transpose into the genome of the recipient strain with a single transposition. Mini-Km2 encodes a gene for kanamycin resistance. [42, 43]
Cultures were maintained in L broth with 15% glycerol at -70°C. Bacteria were cultured in broth or agar at 37°C unless otherwise stated. Appropriate antibiotics were added in concentrations: 50 mg/ml kanamycin, 50 unit/μl polymyxin B.
Isolation and purification of CPS
Frozen stock of NRT36S was streaked for isolation on L agar in 150-mm Petri dishes and incubated overnight. A single bacterial colony from the plate was inoculated into 10 ml of L-broth for 18 h of growth. One ml of the culture was then inoculated into 1-liter L-broth and incubated overnight. Bacterial cells from eight 1-liter batches of culture were pelleted at 10,000 g and resuspended in 120 ml of 0.5X phosphate-buffered saline (PBS) pH 7.5 and shaken at 200 rpm on a rotary shaker for 2 h at room temperature. The bacterial suspensions were centrifuged to remove cell debris at 16,000 g for 20 minutes at 4°C and the supernatant dialyzed with multiple changes of distilled water and concentrated two fold by ultra filtration (100,000-nominal-molecular-weight stirred cell; Amicon, Beverly, Mass). The retentates were then ultra centrifuged at 154,000 g for 2 h at 20°C and the supernatants were removed and digested with RNase A (100 ug/ml) and DNase 1 (50 ug/ml plus 1 mM MgCl2) for 2 h followed by a 3 h digestion with proteinase K(250 ug/ml) and phenol-chloroform extraction. The aqueous layer was dialyzed as described above, and the resultant sample was lyophilized. Purity of the CPS was assessed by bicinchoninic acid protein assay (MicroBCA, Pierce Chemical Co., Rockford Ill.), and Limulus amoebocyte lysate assay (Sigma Chemical Co., St. Louis, Mo.) and by NMR.
Deacylation and preparation of samples for NMR
A sample of 15 mg of CPS in 0.6 ml D2O was subjected to deacylation by 0.3 M ammonium hydroxide for 6 days at 25 C. The 1D 1H spectrum was monitored daily and the sample was lyophilized, exchanged with 99.9% D2O and made up with 0.6 ml pure D2O (de-O-acetyl polysaccharide). A second sample was prepared with milder base treatment in 0.03 M ammonium hydroxide for 5 days at 4°C (mono-O-acetyl polysaccharide). For detection of amide protons, a sample was subjected to deacylation (without D2O exchange) and made up with 0.6 ml 90:10 (v/v) H2O:D2O.
NMR experiments were performed on Bruker 500 MHz DRX AVANCE spectrometer equipped with cryoprobe, with a Bruker 800 MHz DMX AVANCE spectrometer. All Bruker data were processed with NMRPipe and NMRDraw under Linux. All spectra were taken at 50°C due to dynamic properties of the polysaccharide. The following experiments were recorded using standard sequences: 1D: 1H spectrum, 13C spectrum; 2D: ge-DQF-COSY (E/A), ge-TOCSY (DIPSI-2 mixing times 30 and 70 ms, E/A), ge-NOESY (mixing time 50 ms), ge-HSQC (decoupled, E/A), ge-HMBC (long-range evolution time 30 ms, magnitude mode), HSQMBC (long-range evolution time 15 ms), ge-HMQC-COSY (E/A), ge-HSQC-TOCSY (decoupled, DIPSI-2 mixing time 30 ms, E/A). Also the direct 31P and 1D 31P spin-echo difference spectra were measured. For detection of amide protons, the following experiments were recorded on a sample of mono-O-acetyl polysaccharide in 90% H2O/10% D2O solution: 1D: 1H spectrum; 2D: ge-TOCSY (DIPSI-2 mixing time 50 ms, E/A, WATERGATE 3–9–19 combined with presaturation). All chemical shifts are reported relative to internal standard acetone set to 2.225 ppm (1H) and 30.1 ppm (13C).
Methylation analysis was done by means of gas chromatography-mass spectroscopy of partially methylated alditol acetates (performed at Complex Carbohydrate Research Center at University of Georgia). Two hundred μg aliquot of the sample was permethylated following Ciucanu and Kerek . The sample was treated with NaOH and methyl iodide in dry DMSO. The permethylation was repeated twice in order to completely methylate the polymer. Following the permethylation, the sample was hydrolyzed using 2 M HCl for 3 hours at 100°C. Then it was reduced with NaBD4 and acetylated using acetic anhydride/pyridine. The resulting partially methylated alditol acetates were analyzed on HP 5890 GC connected to mass selective detector in ESI ionization mode. The separation was done on 30 m Supelco DB-1 2330 bonded phase fused silica capillary column (0.25 mm ID).
Conjugations were performed between V. cholerae NRT36S as the recipient strain and E. coli S17λpir/putKm2 as the donor strain. Ten μl overnight culture of V. cholerae NRT36S was spotted on LB agar and let dry, 10 μl overnight culture of S17λpir/putKm2 was then spotted on top. After overnight incubation at room temperature, the mixture was re-suspended in 1 ml of LB broth; 50 μl of the suspension was plated onto LB agar with kanamycin and polymyxin B to select for V. cholerae mutants.
DNA flanking the transposon in the mutants was amplified and sequenced by a modified inverse PCR protocol . Genomic DNA was isolated with PrepMan™ (Applied Biosystems) according to the manufacturer's instruction. Two μl genomic DNA of the above preparation was digested with 5 units of Nla III (New England Biolab) in a 20 μl reaction overnight followed by denaturing at 65°C for 15 minutes. Two μl of the digested DNA was self-ligated with 5 units of T4 DNA ligase (Invitrogen) in a 10 μl reaction. One μl of this solution was used as PCR template. Two primers were designed to anneal to the transposon mini-Km2, pointing outwards to amplify the flanking sequence of the mutant genomic DNA. The sequences of the primers are, L8 (Reverse), GTACCGAGCTCGAATTCGGCCTAG; and L9 (forward), GGAGAAAACTCACCGAGGCAGTTC. PCR was performed in a 30 μl reaction containing 100 μM of each dNTP, 1.5 mM of MgCl2, 1x PCR buffer (Invitrogen) and 1 unit of Taq DNA polymerase (Invitrogen). PCR products were purified with the Multiscreen PCR plates (Millipore) and sequenced using the BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems). The resulting fragments were separated and recorded in an ABI 3730 × l automatic sequencer (Applied Biosystems). DNA sequence was then analyzed by the PHRED, PHRAP and CONSED software [46–48].
Complement resistance and EM
Capsule preps were analyzed by SEC using a Beckman Coulter 32 Karat HPLC, with TSK gel column (JOSOHAAS; G3000SWxL; 10 um; 30 cm × 7.5 mm), and detected at 200 nm wavelength. Purified NRT36S capsule was the same sample as used for NMR and methylation analyses. Capsule preps were prepared as followed: 109 cells were harvested into 0.5X PBS and shaken for 2 hours in a rotary shaker at 250 rpm followed by centrifuge at 12000 g for 20 min. The supernatant was treated with Dnase I and Rnase, followed by protease. The supernatant was then extracted with phenol-chloroform and precipitated with ethanol. The pellet was resuspended in water and 1/3 of the amount was loaded.
Immuno blotting was performed as described . Circa 5 × 106 bacterial cells were treated with DNase I, RNase followed by protease. Washed whole cell lysates were run on 16% SDS-polyacrylamide gel and transferred to Immun-Blot PVDF membrane (BioRad, Hercules, CA). Blots were blocked in PBS containing 3% non-fat dry milk and then incubated for 1 h in 1:1000 rabbit antiserum specific for V. cholerae NRT36S. The blots were washed three times with PBS and incubated with alkaline phosphatase-conjugated goat anti-rabbit immunoglobin G (Sigma) at 1:10,000 in PBS for 1 h. The blot was washed five times with PBS and developed with Western Blue colorimetric detection solution (Promega).
Sequencing of V. cholerae NRT36S genome
The genome of NRT36S was sequenced by the company 454 Life Science (454 Life Science, Branford, CT) . The contigs of the draft genome was compared and aligned to the fully sequenced genome of V. cholerae N16961  by Blastn . Gaps between contigs were filled only for the capsule biogenesis region, which contained the genes identified by transposon mutagenesis. Primers were designed for PCR to amplify the fragments of the gaps. PCR products were then sequenced.
Sequence analysis and annotation
Open reading frames were predicted by the program GLIMMER using the DasSarma Laboratory Autoannotation Pipeline (DLAP) (http://halo.umbi.umd.edu/. DasSarma et al., manuscript in preparation). The settings in Glimmer were as in default, with the minimum gene size to be 90 bps and overlapping to be less than 30 bps. BlastX program was used for a similarity search against the protein database in NCBI. We also used Artemis  to edit and confirm the results of GLIMMER.
- CPS – capsule polysaccharide:
LPS – liposaccharide, PCR – polymerase chain reaction, PBS – phosphate buffered saline, SDS – sodium dodeceyl sulfate, SEC size exclusion chromatography, HPLC high pressure liquid chromotagraphy, EM – electron microscopy, NMR nuclear magnetic resonance, HSQC – heteronuclear single quantum correlation, COSY – correlation spectroscopy, NOESY – nuclear Overhauser spectroscopy, TOCSY – total correlation spectroscopy, HMBC – heteronuclear multiple bond coherence
We would like to thank Dr. Shiladitya DasSarma and Beenish Bhatia for the kindly helping in annotating the genome of V. cholerae NRT36S using their server and their script to automate the annotation process. We also thank the company 454 life science for sequencing the genome of V. cholerae NRT36S and the Complex Carbohydrate Research Center at the Univ. of Georgia for carbohydrate analyses as supported by DOE Grant DE-FG09-93ER-20097. We acknowledge support by NSF Grant MCB--212702 and of NIH grant GM-60791.
- Kaper JB, Morris JG, Levine MM: Cholera. Clin Microbiol Rev. 1995, 8 (1): 48-86.PubMed CentralPubMedGoogle Scholar
- Holmgren J, Svennerholm AM: Mechanisms of disease and immunity in cholera: a review. J Infect Dis. 1977, 136 Suppl: S105-12.View ArticlePubMedGoogle Scholar
- Li M, Shimada T, Morris JG, Sulakvelidze A, Sozhamannan S: Evidence for the emergence of non-O1 and non-O139 Vibrio cholerae strains with pathogenic potential by exchange of O-antigen biosynthesis regions. Infect Immun. 2002, 70 (5): 2441-2453. 10.1128/IAI.70.5.2441-2453.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Manning PA, Heuzenroeder MW, Yeadon J, Leavesley DI, Reeves PR, Rowley D: Molecular cloning and expression in Escherichia coli K-12 of the O antigens of the Inaba and Ogawa serotypes of the Vibrio cholerae O1 lipopolysaccharides and their potential for vaccine development. Infect Immun. 1986, 53 (2): 272-277.PubMed CentralPubMedGoogle Scholar
- Morris JG, Takeda T, Tall BD, Losonsky GA, Bhattacharya SK, Forrest BD, Kay BA, Nishibuchi M: Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans. J Clin Invest. 1990, 85 (3): 697-705.PubMed CentralView ArticlePubMedGoogle Scholar
- Yamasaki S, Shimizu T, Hoshino K, Ho ST, Shimada T, Nair GB, Takeda Y: The genes responsible for O-antigen synthesis of vibrio cholerae O139 are closely related to those of vibrio cholerae O22. Gene. 1999, 237 (2): 321-332. 10.1016/S0378-1119(99)00344-3.View ArticlePubMedGoogle Scholar
- Sozhamannan S, Deng YK, Li M, Sulakvelidze A, Kaper JB, Johnson JA, Nair GB, Morris JG: Cloning and sequencing of the genes downstream of the wbf gene cluster of Vibrio cholerae serogroup O139 and analysis of the junction genes in other serogroups. Infect Immun. 1999, 67 (10): 5033-5040.PubMed CentralPubMedGoogle Scholar
- Johnson JA, Joseeph A, Panigrahi P, Morris JG: Frequency of encapsulated versus unencapsulated strains of non-O1 Vibrio cholerae isolated from patients with septicemia of diarrhea, of from environmental strains. American Society for Microbiology annual meeting. 1992, New Orleans, LouisianaGoogle Scholar
- Whitfield C, Roberts IS: Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol Microbiol. 1999, 31 (5): 1307-1319. 10.1046/j.1365-2958.1999.01276.x.View ArticlePubMedGoogle Scholar
- Cox AD, Perry MB: Structural analysis of the O-antigen-core region of the lipopolysaccharide from Vibrio cholerae O139. Carbohydr Res. 1996, 290 (1): 59-65. 10.1016/0008-6215(96)00131-0.View ArticlePubMedGoogle Scholar
- Cox AD, Brisson JR, Varma V, Perry MB: Structural analysis of the lipopolysaccharide from Vibrio cholerae O139. Carbohydr Res. 1996, 290 (1): 43-58. 10.1016/0008-6215(96)00135-8.View ArticlePubMedGoogle Scholar
- Knirel YA, Widmalm G, Senchenkova SN, Jansson PE, Weintraub A: Structural studies on the short-chain lipopolysaccharide of Vibrio cholerae O139 Bengal. Eur J Biochem. 1997, 247 (1): 402-410. 10.1111/j.1432-1033.1997.00402.x.View ArticlePubMedGoogle Scholar
- Simpson LM, White VK, Zane SF, Oliver JD: Correlation between virulence and colony morphology in Vibrio vulnificus. Infect Immun. 1987, 55 (1): 269-272.PubMed CentralPubMedGoogle Scholar
- Chatzidaki-Livanis M, Jones MK, Wright AC: Genetic Variation in the Vibrio vulnificus Group 1 Capsular Polysaccharide Operon. J Bacteriol. 2006, 188 (5): 1987-1998. 10.1128/JB.188.5.1987-1998.2006.PubMed CentralView ArticlePubMedGoogle Scholar
- Wright AC, Powell JL, Kaper JB, Morris JG: Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus. Infect Immun. 2001, 69 (11): 6893-6901. 10.1128/IAI.69.11.6893-6901.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Smith AB, Siebeling RJ: Identification of genetic loci required for capsular expression in Vibrio vulnificus. Infect Immun. 2003, 71 (3): 1091-1097. 10.1128/IAI.71.3.1091-1097.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Structural analysis of carbohydrates. http://www.casper.organ.su.se/sop/sop7.html
- Bergstrom N, Nair GB, Weintraub A, Jansson PE: Structure of the O-polysaccharide from the lipopolysaccharide from Vibrio cholerae O6. Carbohydr Res. 2002, 337 (9): 813-817. 10.1016/S0008-6215(02)00056-3.View ArticlePubMedGoogle Scholar
- Johnson JA, Panigrahi P, Morris JG: Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice. Infect Immun. 1992, 60 (3): 864-869.PubMed CentralPubMedGoogle Scholar
- Panigrahi P, Morris JG: Identification of non-O1 Vibrio cholerae adherence proteins using a Caco-2 cell in vitro system. 93rd General Meeting, American Society for Microbiology, Atlanta, Georgia. 1993Google Scholar
- Chen Y, Johnson JA, Pusch GD, Morris JG, Stine OC: The genome of non-O1 Vibrio cholerae NRT36S demonstrates the presence of pathogenic mechanisms that are distinct from O1 Vibrio cholerae. Infect Immun. 2007Google Scholar
- National Microbial Pathogen Database Resource.http://www.nmpdr.org
- Comstock LE, Johnson JA, Michalski JM, Morris JG, Kaper JB: Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Mol Microbiol. 1996, 19 (4): 815-826. 10.1046/j.1365-2958.1996.407928.x.View ArticlePubMedGoogle Scholar
- Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Umayam L, Gill SR, Nelson KE, Read TD, Tettelin H, Richardson D, Ermolaeva MD, Vamathevan J, Bass S, Qin H, Dragoi I, Sellers P, McDonald L, Utterback T, Fleishmann RD, Nierman WC, White O, Salzberg SL, Smith HO, Colwell RR, Mekalanos JJ, Venter JC, Fraser CM: DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature. 2000, 406 (6795): 477-483. 10.1038/35020000.View ArticlePubMedGoogle Scholar
- Hobbs M, Reeves PR: The JUMPstart sequence: a 39 bp element common to several polysaccharide gene clusters. Mol Microbiol. 1994, 12 (5): 855-856. 10.1111/j.1365-2958.1994.tb01071.x.View ArticlePubMedGoogle Scholar
- Li Q, Hobbs M, Reeves PR: The variation of dTDP-L-rhamnose pathway genes in Vibrio cholerae. Microbiology. 2003, 149 (Pt 9): 2463-2474. 10.1099/mic.0.26382-0.View ArticlePubMedGoogle Scholar
- Cserzo M, Bernassau JM, Simon I, Maigret B: New alignment strategy for transmembrane proteins. J Mol Biol. 1994, 243 (3): 388-396. 10.1006/jmbi.1994.1666.View ArticlePubMedGoogle Scholar
- Reid AN, Whitfield C: functional analysis of conserved gene products involved in assembly of Escherichia coli capsules and exopolysaccharides: evidence for molecular recognition between Wza and Wzc for colanic acid biosynthesis. J Bacteriol. 2005, 187 (15): 5470-5481. 10.1128/JB.187.15.5470-5481.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Feng L, Senchenkova SN, Yang J, Shashkov AS, Tao J, Guo H, Cheng J, Ren Y, Knirel YA, Reeves PR, Wang L: Synthesis of the heteropolysaccharide O antigen of Escherichia coli O52 requires an ABC transporter: structural and genetic evidence. J Bacteriol. 2004, 186 (14): 4510-4519. 10.1128/JB.186.14.4510-4519.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Yildiz FH, Liu XS, Heydorn A, Schoolnik GK: Molecular analysis of rugosity in a Vibrio cholerae O1 El Tor phase variant. Mol Microbiol. 2004, 53 (2): 497-515. 10.1111/j.1365-2958.2004.04154.x.View ArticlePubMedGoogle Scholar
- Frosch M, Weisgerber C, Meyer TF: Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B. Proc Natl Acad Sci U S A. 1989, 86 (5): 1669-1673. 10.1073/pnas.86.5.1669.PubMed CentralView ArticlePubMedGoogle Scholar
- Dolan-Livengood JM, Miller YK, Martin LE, Urwin R, Stephens DS: Genetic basis for nongroupable Neisseria meningitidis. J Infect Dis. 2003, 187 (10): 1616-1628. 10.1086/374740.View ArticlePubMedGoogle Scholar
- Hammerschmidt S, Birkholz C, Zahringer U, Robertson BD, van Putten J, Ebeling O, Frosch M: Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. Mol Microbiol. 1994, 11 (5): 885-896. 10.1111/j.1365-2958.1994.tb00367.x.View ArticlePubMedGoogle Scholar
- Hashimoto Y, Li N, Yokoyama H, Ezaki T: Complete nucleotide sequence and molecular characterization of ViaB region encoding Vi antigen in Salmonella typhi. J Bacteriol. 1993, 175 (14): 4456-4465.PubMed CentralPubMedGoogle Scholar
- Kroll JS, Zamze S, Loynds B, Moxon ER: Common organization of chromosomal loci for production of different capsular polysaccharides in Haemophilus influenzae. J Bacteriol. 1989, 171 (6): 3343-3347.PubMed CentralPubMedGoogle Scholar
- Swartley JS, Ahn JH, Liu LJ, Kahler CM, Stephens DS: Expression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region. J Bacteriol. 1996, 178 (14): 4052-4059.PubMed CentralPubMedGoogle Scholar
- Kondo S, Hisatsune K: Sugar composition of the polysaccharide portion of lipopolysaccharides isolated from non-O1 Vibrio cholerae O2 to O41, O44, and O68. Microbiol Immunol. 1989, 33 (8): 641-648.View ArticlePubMedGoogle Scholar
- Reeves PP, Wang L: Genomic organization of LPS-specific loci. Curr Top Microbiol Immunol. 2002, 264 (1): 109-135.PubMedGoogle Scholar
- Bik EM, Bunschoten AE, Gouw RD, Mooi FR: Genesis of the novel epidemic Vibrio cholerae O139 strain: evidence for horizontal transfer of genes involved in polysaccharide synthesis. Embo J. 1995, 14 (2): 209-216.PubMed CentralPubMedGoogle Scholar
- Stroeher UH, Parasivam G, Dredge BK, Manning PA: Novel Vibrio cholerae O139 genes involved in lipopolysaccharide biosynthesis. J Bacteriol. 1997, 179 (8): 2740-2747.PubMed CentralPubMedGoogle Scholar
- Arita M, Takeda T, Honda T, Miwatani T: Purification and characterization of Vibrio cholerae non-O1 heat-stable enterotoxin. Infect Immun. 1986, 52 (1): 45-49.PubMed CentralPubMedGoogle Scholar
- de Lorenzo V, Herrero M, Jakubzik U, Timmis KN: Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria. J Bacteriol. 1990, 172 (11): 6568-6572.PubMed CentralPubMedGoogle Scholar
- Herrero M, de Lorenzo V, Timmis KN: Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gram-negative bacteria. J Bacteriol. 1990, 172 (11): 6557-6567.PubMed CentralPubMedGoogle Scholar
- Ciucanu I: A simple and rapid method for the permethylation of carbohydrates. Carbohydrate Research. 1984, 131: 209-217. 10.1016/0008-6215(84)85242-8.View ArticleGoogle Scholar
- Martin VJ, Mohn WW: An alternative inverse PCR (IPCR) method to amplify DNA sequences flanking Tn5 transposon insertions. J Microbiol Methods. 1999, 35 (2): 163-166. 10.1016/S0167-7012(98)00115-8.View ArticlePubMedGoogle Scholar
- Ewing B, Green P: Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 1998, 8 (3): 186-194.View ArticlePubMedGoogle Scholar
- Ewing B, Hillier L, Wendl MC, Green P: Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res. 1998, 8 (3): 175-185.View ArticlePubMedGoogle Scholar
- Gordon D: Viewing and Editing Assembled Sequences Using Consed. Current Procols in Bioinformatics. Edited by: Baxevanis AD, Davison DB. 2004, New York , John Wilery & Co., 11.2.1-11.2.43.Google Scholar
- Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol. 1990, 215 (3): 403-410.View ArticlePubMedGoogle Scholar
- Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream MA, Barrell B: Artemis: sequence visualization and annotation. Bioinformatics. 2000, 16 (10): 944-945. 10.1093/bioinformatics/16.10.944.View ArticlePubMedGoogle Scholar